Intensity Modulated Radiotherapy in the Complex Treatment of High-Risk Wilms’ Blastemal Tumor with Thrombosis in the Inferior Vena Cava - A Clinical Case from Our Practice

Authors

  • Lena Marinova Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria. Author
  • Vaska Vasileva Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Nikolay Kahchiev Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Nadezhda Tsvetkova Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Katia Sergieva Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author

DOI:

https://doi.org/10.47363/JPRRR/2026(8)205

Keywords:

High-Risk Blastemal Nephroblastoma, Inferior Vena Cava Thrombosis, Complex Treatment, Surgery, Postoperative Radiotherapy, Chemotherapy

Abstract

Nephroblastoma is a malignant tumor that is diagnosed in children under 5 years of age. Complex treatment is required, including chemotherapy, surgery and, if necessary, local abdominal radiotherapy. The high-risk group with diffuse anaplastic or blastemal nephroblastoma after completion of chemotherapy (Ch) requires careful consideration of the timing of surgical intervention and the necessary postoperative radiotherapy.


We present this a child with high-risk blastematal type nephroblastoma with thrombosis in the inferior vena cava to emphasize how important and significant it is to carry out all components in the complex treatment, namely preoperative chemotherapy, surgical treatment, postoperative local radiotherapy, postoperative chemotherapy, and in the case of pulmonary metastases, if possible, their surgical removal and the conduct of radiotherapy to both lungs.

Author Biographies

  • Lena Marinova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria.

    Lena Marinova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria.

  • Vaska Vasileva, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

  • Nikolay Kahchiev, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

  • Nadezhda Tsvetkova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

  • Katia Sergieva, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

Downloads

Published

2026-10-12